{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:23:49Z","timestamp":1774621429596,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inhalation of sulfur dioxide (SO2) causes bronchoconstriction in most people with asthma. To examine the role of leukotrienes in this response, the antagonism of SO2-induced bronchoconstriction by a single oral dose of the leukotriene receptor antagonist zafirlukast was assessed in a double-blind, placebo-controlled, two-period crossover trial in 12 subjects with mild-to-moderate asthma. Subjects had bronchial hyperresponsiveness, an FEV1 \u2265 70% of predicted, and a positive response to inhaled SO2 (an 8-unit increase in specific airway resistance on inhaling an SO2 concentration of \u2264 4 ppm (PC8SRaw). Subjects were treated with zafirlukast (20 mg) or placebo on two treatment days 5 to 14 d apart. Two and 10 hours after treatment, subjects inhaled SO2 (0.25, 0.5, 1.0, 2.0, 4.0, and 8.0 ppm) during eucapnic hyperventilation at 20 L\/min. PC8SRaw was determined after each challenge. Blood samples were collected to assess zafirlukast plasma concentrations versus effect. PC8SRaw was significantly higher 2 h after zafirlukast compared with placebo (3.1 versus 1.5 ppm; p = 0.02) and remained higher 10 h after treatment with zafirlukast (2.7 versus 1.9 ppm; p = 0.09). An association was found between zafirlukast plasma concentrations and increases in PC8SRaw 10 h after treatment (p = 0.001). The safety profile of zafirlukast was not clinically different from placebo. A single 20-mg dose of zafirlukast attenuated SO2-induced bronchoconstriction. We conclude that SO2-induced bronchoconstriction involves release of leukotrienes and that treatment with zafirlukast attenuates the bronchoconstrictor response.<\/jats:p>","DOI":"10.1164\/ajrccm.156.6.9608006","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:26:37Z","timestamp":1365081997000},"page":"1725-1730","source":"Crossref","is-referenced-by-count":42,"title":["The Leukotriene Receptor Antagonist Zafirlukast Inhibits Sulfur Dioxide\u2013induced Bronchoconstriction in Patients with Asthma"],"prefix":"10.1093","volume":"156","author":[{"given":"STEPHEN C.","family":"LAZARUS","sequence":"first","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco, California, and Zeneca Pharmaceuticals, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HOFER H.","family":"WONG","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco, California, and Zeneca Pharmaceuticals, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHAEL J.","family":"WATTS","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco, California, and Zeneca Pharmaceuticals, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HOMER A.","family":"BOUSHEY","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco, California, and Zeneca Pharmaceuticals, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BERNARD J.","family":"LAVINS","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco, California, and Zeneca Pharmaceuticals, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARGARET C.","family":"MINKWITZ","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco, California, and Zeneca Pharmaceuticals, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1997,12,1]]},"reference":[{"key":"2026032709260114000_B1","first-page":"873","article-title":"Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide.","volume":"122","author":"Sheppard","year":"1980","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1152\/jappl.1965.20.1.164","article-title":"Mechanism of bronchoconstriction during inhalation of sulfur dioxide.","volume":"20","author":"Nadel","year":"1965","journal-title":"J. Appl. Physiol."},{"key":"2026032709260114000_B3","first-page":"250","article-title":"Effect of increasing doses of ipratropium bromide on dose-response curve to isocapnic hyperventilation with cold air in asthmatic subjects (abstract).","volume":"127","author":"Tam","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B4","first-page":"1154","article-title":"Interaction of cromolyn and a muscarinic antagonist in inhibiting bronchial reactivity to sulfur dioxide and to eucapnic hyperpnea alone.","volume":"133","author":"Meyers","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B5"},{"key":"2026032709260114000_B6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00039896.1975.10666706","article-title":"Ammonium and sulfate ion release histamine from lung fragments.","volume":"30","author":"Charles","year":"1975","journal-title":"Arch. Environ. Health"},{"key":"2026032709260114000_B7","first-page":"257","article-title":"Inhibition of sulfur dioxide\u2013induced bronchoconstriction by disodium cromoglycate in asthmatic subjects.","volume":"124","author":"Sheppard","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0091-6749(93)90106-P","article-title":"Effects of nedocromil sodium on the bronchomotor response to sulfur dioxide in asthmatic patients.","volume":"92","author":"Bigby","year":"1993","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709260114000_B9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/288484a0","article-title":"Leukotrienes are potent constrictors of human bronchi.","volume":"288","author":"Dahl\u00e9n","year":"1980","journal-title":"Nature"},{"key":"2026032709260114000_B10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/290343a0","article-title":"Slow reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro.","volume":"290","author":"Hanna","year":"1981","journal-title":"Nature"},{"key":"2026032709260114000_B11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1164\/ajrccm\/142.1.112","article-title":"Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge.","volume":"142","author":"Wenzel","year":"1990","journal-title":"Am. Rev. Respir. Dis"},{"key":"2026032709260114000_B12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0091-6749(91)90013-E","article-title":"Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses.","volume":"87","author":"Wenzel","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709260114000_B13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1164\/ajrccm\/141.6.1441","article-title":"Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans: effect of indomethacin.","volume":"141","author":"Sladek","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/ajrccm\/146.1.104","article-title":"Recovery of leukotriene E4 from the urine of patients with airway obstruction.","volume":"146","author":"Drazen","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0140-6736(91)90277-V","article-title":"Effect of a cysteinyl-leukotriene receptor antagonist, ICI 204,219 on allergen-induced bronchoconstriction and airway hyper-reactivity in atopic subjects.","volume":"337","author":"Taylor","year":"1991","journal-title":"Lancet"},{"key":"2026032709260114000_B16","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0091-6749(92)90227-S","article-title":"Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma.","volume":"89","author":"Findlay","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709260114000_B17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1164\/ajrccm\/145.4_Pt_1.746","article-title":"Role of leukotrienes in exercise-induced asthma: inhibitory effect of ICI 204,219, a potent leukotriene D4 receptor antagonist.","volume":"145","author":"Finnerty","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1172\/JCI103282","article-title":"A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.","volume":"35","author":"Dubois","year":"1956","journal-title":"J. Clin. Invest."},{"key":"2026032709260114000_B19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-4347(97)00092-3","article-title":"Determination of zafirlukast, a selective leukotriene antagonist, in human plasma by normal phase high-performance chromatography with fluorescence detection.","volume":"696","author":"Bui","year":"1997","journal-title":"J. Chromatogr. B."},{"key":"2026032709260114000_B20"},{"key":"2026032709260114000_B21"},{"key":"2026032709260114000_B22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/clpt.1993.170","article-title":"Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.","volume":"54","author":"Smith","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"2026032709260114000_B23"},{"key":"2026032709260114000_B24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.pu.02.050181.002145","article-title":"Air pollution and respiratory disease.","volume":"2","author":"Whittemore","year":"1981","journal-title":"Annu. Rev. Publ. Health"},{"key":"2026032709260114000_B25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1289\/ehp.897973","article-title":"Reexamination of London, England, mortality in relation to exposure to acidic aerosols during 1963-1972 winters.","volume":"79","author":"Thurston","year":"1989","journal-title":"Environ. Health Perspect."},{"key":"2026032709260114000_B26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/oxfordjournals.aje.a115473","article-title":"Mortality and air pollution in London: a time series analysis.","volume":"131","author":"Schwartz","year":"1990","journal-title":"Am. J. Epidemiol."},{"key":"2026032709260114000_B27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0140-6736(53)91012-5","article-title":"Mortality in the London fog incident.","volume":"1","author":"Logan","year":"1953","journal-title":"Lancet"},{"key":"2026032709260114000_B28","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/oxfordjournals.aje.a112836","article-title":"Health effects of particulate pollution: reappraising the evidence.","volume":"110","author":"Holland","year":"1979","journal-title":"Am. J. Epidemiol."},{"key":"2026032709260114000_B29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1152\/jappl.1962.17.2.252","article-title":"Effects of acute controlled exposure to SO2 on respiratory mechanics in healthy male adults.","volume":"17","author":"Frank","year":"1962","journal-title":"J. Appl. Physiol."},{"key":"2026032709260114000_B30","first-page":"486","article-title":"Exercise increases sulfur dioxide\u2013induced bronchoconstriction in asthmatic subjects.","volume":"123","author":"Sheppard","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B31","first-page":"592","article-title":"Effect of exercise rate and route of inhalation on sulfur-dioxide\u2013induced bronchoconstriction in asthmatic subjects.","volume":"128","author":"Bethel","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032709260114000_B32","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0091-6749(05)80155-1","article-title":"Comparison of the effect of inhaled corticosteroids on the airway response to histamine, methacholine, hyperventilation, and sulfur dioxide in subjects with asthma.","volume":"86","author":"Wiebicke","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026032709260114000_B33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(92)90790-B","article-title":"The effect of nedocromil sodium on the isolated rabbit vagus nerve.","volume":"221","author":"Jackson","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"2026032709260114000_B34","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1152\/jappl.1993.75.6.2797","article-title":"Role of eicosanoids in hyperpnea-induced airway responses in guinea pigs.","volume":"75","author":"Garland","year":"1993","journal-title":"J. Appl. Physiol."},{"key":"2026032709260114000_B35","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1514","article-title":"Augmented muscarinic responsiveness caused by 5-lipoxygenase products secreted from alveolar macrophages in isolated-perfused rat lung.","volume":"147","author":"Padrid","year":"1993","journal-title":"Am. Rev. Respir. Dis."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/156\/6\/1725\/67451120\/ajrccm_156_6_1725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/156\/6\/1725\/67451120\/ajrccm_156_6_1725.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:26:12Z","timestamp":1774617972000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/156\/6\/1725\/8531120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12,1]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1997,12,1]]},"published-print":{"date-parts":[[1997,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.156.6.9608006","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,12]]},"published":{"date-parts":[[1997,12,1]]}}}